Amoebiasis: Difference between revisions
| Line 2: | Line 2: | ||
<br><b>Background Information</b> | <br><b>Background Information</b> | ||
Amoebiasis was first identified by Hippocrates around 300 B.C., in which he described a patient displaying symptoms of fever and dysentery. Throughout the world, amoebiasis is the second leading cause of death from a parasitic disease with an estimated 70,000 deaths per year. However, most of these cases occur in the developing world. Amoebiasis is a gastrointestinal infection due to the amoeba, | Amoebiasis was first identified by Hippocrates around 300 B.C., in which he described a patient displaying symptoms of fever and dysentery. Throughout the world, amoebiasis is the second leading cause of death from a parasitic disease with an estimated 70,000 deaths per year. However, most of these cases occur in the developing world. Amoebiasis is a gastrointestinal infection due to the amoeba, Entamoeba histolytica. Although it accounts for a large number of deaths every year, about 90% of the people exposed to E. histolytica are asymptomatic. | ||
<br><b>Transmission</b> | <br><b>Transmission</b> | ||
Revision as of 01:12, 8 November 2013
Introduction
Background Information
Amoebiasis was first identified by Hippocrates around 300 B.C., in which he described a patient displaying symptoms of fever and dysentery. Throughout the world, amoebiasis is the second leading cause of death from a parasitic disease with an estimated 70,000 deaths per year. However, most of these cases occur in the developing world. Amoebiasis is a gastrointestinal infection due to the amoeba, Entamoeba histolytica. Although it accounts for a large number of deaths every year, about 90% of the people exposed to E. histolytica are asymptomatic.
Transmission
Entamoeba histolytica Lifecycle
Prognosis/Treatment
"E. histolytica contains proteolytic enzymes (collagenase and neutral proteases) and cysteine proteases, which presumably facilitate its tissue invasion. The parasite also elaborates a range of enzymes on the amebic surface, including membrane-associated neuraminidase and β-glucosaminidase (166, 223, 234)."
At right is a sample image insertion. It works for any image uploaded anywhere to MicrobeWiki. The insertion code consists of:
Double brackets: [[
Filename: PHIL_1181_lores.jpg
Thumbnail status: |thumb|
Pixel size: |300px|
Placement on page: |right|
Legend/credit: Electron micrograph of the Ebola Zaire virus. This was the first photo ever taken of the virus, on 10/13/1976. By Dr. F.A. Murphy, now at U.C. Davis, then at the CDC.
Closed double brackets: ]]
Other examples:
Bold
Italic
Subscript: H2O
Superscript: Fe3+
Section 1
Therapy Developments of Amoebiasis
Section 2
Development of Diagnoses Methods It is important to have as precise methods as possible in detecting E. histolytica in order to determine the extent of the amoebiasis infection. Furthermore, the more that is understood about E. histolytic, researchers are better to develop treatments.
Microscopy/Biochemical Methods Microscopy has historically been the most prominent method of detecting E. histolytica. However, researchers are now discovering that it is difficult to to detect morphological differences among similar protozoa. There is another emerging problem becoming apparent with diagnosing amoebiasis with microscopy: ELISA
Conclusion
Overall text length should be at least 1,000 words (before counting references), with at least 2 images. Include at least 5 references under Reference section.
References
Edited by [Author Name], student of Joan Slonczewski for BIOL 116 Information in Living Systems, 2013, Kenyon College.
